Squarepoint
STIM icon

Squarepoint’s Neuronetics STIM Stock Holding History

Squarepoint’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$123K Buy
94,616
+57,000
+152% +$82.9K ﹤0.01% 4170
2026
Q1 		$54.5K Buy
37,616
+14,410
+62% +$22.8K ﹤0.01% 4133
2025
Q4 		$32K Sell
23,206
-39,252
-63% -$82.1K ﹤0.01% 4153
2025
Q3 		$171K Buy
62,458
+10,423
+20% +$37K ﹤0.01% 3991
2025
Q2 		$182K Sell
52,035
-135,926
-72% -$537K ﹤0.01% 4009
2025
Q1 		$692K Buy
+187,961
New +$686K ﹤0.01% 2991
2024
Q3 		– Sell
-14,773
Closed -$26.6K – 4675
2024
Q2 		$26.6K Sell
14,773
-5,325
-26% -$15.4K ﹤0.01% 3949
2024
Q1 		$95.7K Buy
+20,098
New +$70.6K ﹤0.01% 3805
2023
Q4 		– Sell
-23,833
Closed -$32.2K – 4484
2023
Q3 		$32.2K Buy
23,833
+8,258
+53% +$14.5K ﹤0.01% 3673
2023
Q2 		$33.5K Sell
15,575
-1,678
-10% -$4.07K ﹤0.01% 3468
2023
Q1 		$50.2K Buy
+17,253
New +$87K ﹤0.01% 3058
2020
Q4 		– Sell
-42,482
Closed -$206K – 3244
2020
Q3 		$206K Buy
+42,482
New +$161K ﹤0.01% 2072
2020
Q1 		– Sell
-33,585
Closed -$151K – 2482
2019
Q4 		$151K Buy
33,585
+12,870
+62% +$80K ﹤0.01% 2283
2019
Q3 		$172K Buy
+20,715
New +$226K ﹤0.01% 2113

Other funds holding STIM

MAM
Madryn Asset Management New York $36.9M AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Squarepoint's STIM Position: Q2 2026 in Review

Squarepoint increased its Neuronetics (STIM) stake by 152% in Q2 2026, buying an estimated $82.9K and bringing the position to 94,616 shares worth $123K. The position accounts for ﹤0.01% of the portfolio, ranked #4170.

Squarepoint first reported a position in STIM in Q3 2019 and has held it in 14 quarters since. The position peaked at $692K in Q1 2025. 87 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • Squarepoint held 94,616 shares of Neuronetics worth $123K as of Q2 2026.
  • Squarepoint bought 57,000 Neuronetics shares in Q2 2026, an estimated $82.9K.
  • Neuronetics made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #4170 holding.
  • Squarepoint first reported a position in Neuronetics in Q3 2019 and has held it in 14 quarters since.
  • Squarepoint's Neuronetics position peaked at $692K in Q1 2025.
  • 87 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.